Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery

Mater Sci Eng C Mater Biol Appl. 2017 Jan 1;70(Pt 1):378-385. doi: 10.1016/j.msec.2016.09.003. Epub 2016 Sep 6.

Abstract

In recent years, nanoparticles (NPs) based on biopolymers or peptides are gaining popularity for the encapsulation and release of drug molecules, especially for cancer therapy, due to their ability for targeted and controlled release. The use of collagen peptide (CP) for the preparation of chitosan (CN) NPs is especially interesting as it results in NPs that are stable under physiological conditions. In this work, mono-dispersed pH responsive CPCN NPs of about 100nm were prepared via ionic gelation method by simple and mild co-precipitation of CN and CP. Investigation of NPs with Fourier transform infra-red (FTIR) spectroscopy and dynamic light scattering (DLS) measurements reveals that hydrogen bonding and electrostatic interactions are believed to be major driving forces for NP formation and drug encapsulation, respectively. Scanning electron microscopic (SEM) investigations show that hard and fine CPCN NPs transform to soft and bigger gel like particles as a function of collagen concentration. The unique "polymeric gel" structure of NPs showed high encapsulation efficiency towards doxorubicin hydrochloride (DOX) as well as pH controlled release. Anti-proliferative and cell viability analysis revealed that DOX loaded NPs showed excellent anti-proliferative characteristics against HeLa cells with favorable biocompatibility against normal cells. Such NPs have high potential for use as smart drug delivery carriers in advanced cancer therapy.

Keywords: Chitosan nanoparticles; Collagen peptide; Doxorubicin; Ionic gelation; Molecular interactions.

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Chitosan / chemistry*
  • Collagen / chemistry*
  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use*
  • Drug Carriers / chemistry*
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Flow Cytometry
  • HeLa Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Mice
  • NIH 3T3 Cells
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Particle Size
  • Peptides / chemistry*
  • Spectroscopy, Fourier Transform Infrared
  • Time Factors
  • X-Ray Diffraction

Substances

  • Drug Carriers
  • Peptides
  • Doxorubicin
  • Collagen
  • Chitosan